Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
University of Paris-Saclay
Gif-sur-Yvette, FranciaPublicaciones en colaboración con investigadores/as de University of Paris-Saclay (47)
2024
-
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Molecular Cancer, Vol. 23, Núm. 1
-
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 7, pp. 1891-1908
2023
-
Correction: Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies (Critical Care, (2023), 27, 1, (3), 10.1186/s13054-022-04294-5)
Critical Care
-
Corrigendum: Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effect, (Front. Oncol, (2022), 12, (1037262), 10.3389/fonc.2022.1037262)
Frontiers in Oncology
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
2022
-
An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular Carcinoma
Cancers, Vol. 14, Núm. 11
-
Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
Nutrients, Vol. 14, Núm. 1
-
Minimally Invasive Donor Hepatectomy for Adult Living Donor Liver Transplantation An International, Multi-institutional Evaluation of Safety, Efficacy and Early Outcomes
Annals of Surgery, Vol. 275, Núm. 1, pp. 166-174
-
Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effect
Frontiers in Oncology, Vol. 12
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
Scientific Reports, Vol. 12, Núm. 1
-
World Survey on Minimally Invasive Donor Hepatectomy: A Global Snapshot of Current Practices in 2370 Cases
Transplantation, Vol. 106, Núm. 1, pp. 96-105
2021
-
Association of the lung immune prognostic index with immunotherapy outcomes in mismatch repair deficient tumors
Cancers, Vol. 13, Núm. 15
-
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320
-
Erratum to “IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper” [World Allergy Organ J 13/2 (2020) 100080] (World Allergy Organization Journal (2020) 13(2), (S1939455119312360), (10.1016/j.waojou.2019.100080))
World Allergy Organization Journal
-
Expert consensus guidelines on minimally invasive donor hepatectomy for living donor liver transplantation from innovation to implementation: A joint initiative from the international laparoscopic liver society (ILLS) and the Asian-Pacific hepato-pancreato-biliary association (A-PHPBA)
Annals of Surgery, Vol. 273, Núm. 1, pp. 96-108
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Monitoring established Crohn’s disease with pan-intestinal video capsule endoscopy in Europe: clinician consultation using the nominal group technique
Current Medical Research and Opinion, Vol. 37, Núm. 9, pp. 1547-1554
-
Patterns of progression in patients treated for immuno-oncology antibodies combination
Cancer Immunology, Immunotherapy, Vol. 70, Núm. 1, pp. 221-232
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
The Lancet Diabetes and Endocrinology, Vol. 9, Núm. 8, pp. 491-501